retatrutide type 2 diabetes trial results 2024 2025 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished 🚨Breaking: Retatrutide's first Phase 3

Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy

Product Overview Item # 01405230 Servings per Container 60 Form Capsule Product Description Features Each capsule provides 500mg L-Glutathione Added with Vitamin C for added antioxidant Glutathione levels decline with age & daily stressors such as poor diet, pollution, lack of sleep and constant stress further depletes our bodys level

CJC-1295 (with DAC) CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to promote pulsatile release of endogenous GH over extended periods

But it's the drug the longevity community is watching most closely